Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for CME in Retinitis Pigmentosa
NCT02140164Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- May 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in retinitis pigmentosa (RP), cystoid macular edema (CME), sponsored by National Eye Institute. Started May 2014; status: completed.
02
Drugs
minocycline
03
Conditions
retinitis pigmentosa (RP)cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT02140164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140164.